Neurovalens Competitors and Similar CompaniesClear all
Neurovalens's competitors and similar companies include Synapse Biomedical and Blue Note Therapeutics.
 Synapse Biomedical Synapse Biomedical (SBI) is a company dedicated to the research, development, and commercialization of life-altering neurostimulation products. |  Blue Note Therapeutics Blue Note Therapeutics is a company developing prescription digital therapeutics designed to reduce anxiety, depression, and other distress related to cancer. | ||
Founding Date | Founding Date 2013 | Founding Date 2002 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Belfast, GB HQ | Locations Oberlin, US HQ Paris, FR | Locations San Francisco, US HQ |
Employees | Employees 30 | Employees 313% increase | Employees 6 |
Funding | |||
Latest funding round | Latest funding round $ 5.8m (almost 6 years ago) | Latest funding round $ 2.4m (over 12 years ago) | Latest funding round $ 5.2m (almost 5 years ago) |
Total funding raised | Total funding raised $ 16.3m | Total funding raised $ 3.1m | Total funding raised $ 31.5m |
For sources of this data, please see the company profile
View Company Profiles
Synapse Biomedical
HQ
Oberlin, US
Employees
31↑ 3% increase
Synapse Biomedical (SBI) is a company dedicated to the research, development, and commercialization of life-altering neurostimulation products.
View companyBlue Note Therapeutics
HQ
San Francisco, US
Employees
6
Blue Note Therapeutics is a company developing prescription digital therapeutics designed to reduce anxiety, depression, and other distress related to cancer.
View company